Attempts have been made to understand the role of antifungal CD8+ T cells in the absence of CD4+ T cells, a potential avenue to exploit residual immunity for preventive and therapeutic purposes for individuals with CD4+ T-cell lymphopenia. The gene discussed is CD4; the disease is lymphopenia.